{"id":21598,"date":"2026-10-12T12:37:43","date_gmt":"2026-10-12T10:37:43","guid":{"rendered":"https:\/\/www.jcc-holland.nl\/?p=21598"},"modified":"2026-10-12T13:04:42","modified_gmt":"2026-10-12T11:04:42","slug":"21598","status":"publish","type":"post","link":"https:\/\/www.jcc-holland.nl\/en\/21598\/","title":{"rendered":""},"content":{"rendered":"<p style=\"text-align: center;\"><span style=\"text-decoration: underline;\"><span style=\"font-size: 14pt;\"><strong><span style=\"color: #ff6600; text-decoration: underline;\">Regenerative Medicine delegation from Japan<\/span><\/strong><strong>\u00a0<\/strong><\/span><\/span><\/p>\n<p style=\"text-align: center;\">You can download the <a href=\"https:\/\/www.jcc-holland.nl\/uploads\/2026\/10\/Delegation-Japan-networking-event-28-10.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #ff6600;\"><span style=\"text-decoration: underline;\"><strong>list as pdf<\/strong><\/span> .<\/span><\/a><\/p>\n<ol>\n<li><strong> Jun Miyagawa, Assistant to the Chairman &#8211; Nakanoshima Qross and President &amp; CEO of Miracle Science Innovation Inc <\/strong><\/li>\n<\/ol>\n<p><strong>\u00a0<\/strong>Key interest areas:<\/p>\n<p>Regenerative-medicine ecosystem hub; startup &amp; venture support<\/p>\n<p><strong>\u00a0<\/strong>Website:<a href=\"https:\/\/www.nakanoshima-qross.jp\/en\/\">Nakanoshima Qross<\/a><a href=\"https:\/\/www.nakanoshima-qross.jp\/en\">\u00a0<\/a>\uff08English)<\/p>\n<p><a href=\"https:\/\/www.nakanoshima-qross.jp\/\" target=\"_blank\" rel=\"noopener\">Nakanoshima Qross\uff08\u4e2d\u4e4b\u5cf6\u30af\u30ed\u30b9\uff09<\/a> (\u65e5\u672c\u8a9e\uff09<\/p>\n<ol start=\"2\">\n<li><strong> Hiroki Iguchi, Marketing &amp; Business Development Manager, Cell Culture Business <\/strong><strong>Group\/Life Science Business Development Department &#8211; Sekisui Chemical\u00a0<\/strong><\/li>\n<\/ol>\n<p>Key interest areas:<\/p>\n<p>member of the value chain consortium for development of Mass Cell Culture System (VMaCS); cell culture scaffold material Ceglu\u2122; stable cell manufacturing<\/p>\n<p>Website: <a href=\"https:\/\/www.sekisuichemical.com\/\">SEKISUI CHEMICAL CO.,LTD<\/a><\/p>\n<ol start=\"3\">\n<li><strong> Keiko Okamura, Director, General Manager of Business Management Division &#8211; Gojo Medical <\/strong><\/li>\n<\/ol>\n<p><strong>\u00a0<\/strong>Key interest areas:<\/p>\n<p>member of the value chain consortium for development of Mass Cell Culture System (VMaCS); ultra-low-temperature logistics &amp; asset-based 3PL; pharma\/medical device transport<\/p>\n<p>Website : <a href=\"https:\/\/gojyo-med.co.jp\" target=\"_blank\" rel=\"noopener\">https:\/\/gojyo-med.co.jp<\/a><\/p>\n<ol start=\"4\">\n<li><strong> Kazuo Omori, President &amp; CEO &#8211; Revascular Bio Inc (Bio venture from Osaka University)<\/strong><\/li>\n<\/ol>\n<p><strong>\u00a0<\/strong>Key interest areas:<\/p>\n<p>Vascular endothelial stem cells; therapies for vascular disorders; regenerative-medicine drug discovery<\/p>\n<p>Website:\u00a0<a href=\"https:\/\/revascularbio.com\/en\/\">Revascular Bio<\/a><\/p>\n<ol start=\"5\">\n<li><strong> Kazuyoshi Hirao, Director &amp; Chief Business Officer &#8211; Quorips <\/strong><\/li>\n<\/ol>\n<p>Key interest areas:<\/p>\n<p>iPS cell-derived cardiomyocyte sheets; EMA; European expansion;\u00a0 value chain consortium for development of Mass Cell Culture System (VMaCS) lead<\/p>\n<p>Website:<a href=\"https:\/\/www.cuorips.co.jp\/en\">Cuorips Inc. | Pioneering the Future of Cell Therapeutics<\/a><\/p>\n<ol start=\"6\">\n<li><strong> Nariaki Yanagawa, Assistant Manager Regenerative Engineering R&amp;D Department &#8211; Saraya <\/strong><\/li>\n<\/ol>\n<p>Key interest areas:<\/p>\n<p>Hygiene &amp; infection control; cell manufacturing environments; overseas business<\/p>\n<p>Website:\u00a0<a href=\"https:\/\/saraya.world\/\">SARAYA &#8211; Home<\/a><\/p>\n<ol start=\"7\">\n<li><strong> Daisuke Akabane, Sr. Manager Clinical Team\/Business Development Department &#8211; VC cell therapy Inc. (Vision Care)<\/strong><\/li>\n<\/ol>\n<p>Key interest areas:<\/p>\n<p>iPS-derived retinal pigment epithelium cells; Kobe Eye Center; ophthalmic regenerative medicine<\/p>\n<p>Website:\u00a0<a href=\"https:\/\/www.vcct.jp\/en\/\">HOME | \u682a\u5f0f\u4f1a\u793e VC Cell Therapy<\/a><\/p>\n<ol start=\"8\">\n<li><strong> Kasane Ogura, Advanced Medical Business Development Collaboration Office &#8211; iPS Portal<\/strong><\/li>\n<\/ol>\n<p>Key interest areas: iPS cell R&amp;D and commercialization support; disease specific iPS cell banking; regenerativemedicine services (Kyoto\/CiRA ecosystem)<\/p>\n<p>Website: <a href=\"https:\/\/ipsportal.com\/en\/\">iPS Portal, Inc<\/a><\/p>\n<ol start=\"9\">\n<li><strong> Masaaki Shimokoshi ,<\/strong> <strong>General Manager International Program Department &#8211; Japan Asia Medical Investment Co., Ltd (Japan entity of Hong Kong Asia\u00a0 Medical Group) \/ Sapporo Cardio Vascular Clinic<\/strong><\/li>\n<\/ol>\n<p>Key interest areas:<\/p>\n<p>Heart centers and hospitals in China, HK, Japan, and Indonesia. Candidate clinical site for cardiac cell therapy implementation<\/p>\n<p>Website: <a href=\"https:\/\/www.hkam-group.com\/en-GB\">Home | HK Asia Medical Group<\/a><\/p>\n<ol start=\"10\">\n<li><strong> Hajime Oji , Digital Healthcare and Future Cities Division, Medical &amp; Healthcare and Smart City Business Division &#8211; NEC Corporation \/ Fones Life Co., Ltd. (TBC)<\/strong><strong>\u00a0<\/strong><\/li>\n<\/ol>\n<p>Website<a href=\"https:\/\/group.nec\/global\/en\/\">:\u00a0<\/a><\/p>\n<ol start=\"11\">\n<li><strong>Representative from Chitose Bio (TBC) <\/strong><\/li>\n<\/ol>\n<p>Specializes in technological development aimed at maximizing breeding and cultivation technologies for microorganisms, microalgae, and cultured cells to a commercial level and bringing them to market. The company collaborates with Fujifilm in the biopharmaceutical field. The company contributes to gene therapy through initiatives such as the development of HAT cell lines (collaborating with Osaka University).<\/p>\n<p>Website:\u00a0<a href=\"https:\/\/chitose-bio.com\/\">CHITOSE Group | Family of Biotechnology Companies Leading the Global Bioeconomy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"excerpt\">Regenerative Medicine delegation from Japan\u00a0 You can download the list as pdf . Jun Miyagawa, Assistant to the Chairman &#8211; Nakanoshima Qross and President &amp; CEO of Miracle Science Innovation Inc \u00a0Key interest areas: Regenerative-medicine ecosystem hub; startup &amp; venture support \u00a0Website:Nakanoshima Qross\u00a0\uff08English) Nakanoshima Qross\uff08\u4e2d\u4e4b\u5cf6\u30af\u30ed\u30b9\uff09 (\u65e5\u672c\u8a9e\uff09 Hiroki Iguchi, Marketing &amp; Business Development Manager, Cell Culture Business Group\/Life Science Business Development Department &#8211; Sekisui Chemical\u00a0 Key interest areas: member of the value chain consortium for development of Mass Cell Culture System (VMaCS); cell culture scaffold material Ceglu\u2122; stable cell manufacturing Website: SEKISUI CHEMICAL CO.,LTD Keiko Okamura, Director, General Manager of Business Management Division &#8211; Gojo Medical \u00a0Key interest areas: member of [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-21598","post","type-post","status-publish","format-standard","hentry","category-1"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>- \u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.jcc-holland.nl\/en\/21598\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"- \u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240\" \/>\n<meta property=\"og:description\" content=\"Regenerative Medicine delegation from Japan\u00a0 You can download the list as pdf . Jun Miyagawa, Assistant to the Chairman &#8211; Nakanoshima Qross and President &amp; CEO of Miracle Science Innovation Inc \u00a0Key interest areas: Regenerative-medicine ecosystem hub; startup &amp; venture support \u00a0Website:Nakanoshima Qross\u00a0\uff08English) Nakanoshima Qross\uff08\u4e2d\u4e4b\u5cf6\u30af\u30ed\u30b9\uff09 (\u65e5\u672c\u8a9e\uff09 Hiroki Iguchi, Marketing &amp; Business Development Manager, Cell Culture Business Group\/Life Science Business Development Department &#8211; Sekisui Chemical\u00a0 Key interest areas: member of the value chain consortium for development of Mass Cell Culture System (VMaCS); cell culture scaffold material Ceglu\u2122; stable cell manufacturing Website: SEKISUI CHEMICAL CO.,LTD Keiko Okamura, Director, General Manager of Business Management Division &#8211; Gojo Medical \u00a0Key interest areas: member of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.jcc-holland.nl\/en\/21598\/\" \/>\n<meta property=\"og:site_name\" content=\"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-12T10:37:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-12T11:04:42+00:00\" \/>\n<meta name=\"author\" content=\"suzuki\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"suzuki\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/\"},\"author\":{\"name\":\"suzuki\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#\\\/schema\\\/person\\\/22f3f93b50b96f44a4bbeed61055a77d\"},\"headline\":\"No title\",\"datePublished\":\"2026-10-12T10:37:43+00:00\",\"dateModified\":\"2026-10-12T11:04:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/\"},\"wordCount\":457,\"publisher\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#organization\"},\"articleSection\":[\"\u30ab\u30c6\u30b4\u30ea\u30fc\u306a\u3057\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/\",\"url\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/\",\"name\":\"- \u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#website\"},\"datePublished\":\"2026-10-12T10:37:43+00:00\",\"dateModified\":\"2026-10-12T11:04:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/21598\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.jcc-holland.nl\\\/en\\\/uncategorized\\\/\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#website\",\"url\":\"https:\\\/\\\/www.jcc-holland.nl\\\/\",\"name\":\"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240\",\"description\":\"THE JAPANESE CHAMBER OF COMMERCE AND INDUSTRY IN THE NETHERLANDS\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.jcc-holland.nl\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#organization\",\"name\":\"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240\",\"url\":\"https:\\\/\\\/www.jcc-holland.nl\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.jcc-holland.nl\\\/uploads\\\/2017\\\/11\\\/logo_JP_01.png\",\"contentUrl\":\"https:\\\/\\\/www.jcc-holland.nl\\\/uploads\\\/2017\\\/11\\\/logo_JP_01.png\",\"width\":84,\"height\":70,\"caption\":\"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240\"},\"image\":{\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.jcc-holland.nl\\\/#\\\/schema\\\/person\\\/22f3f93b50b96f44a4bbeed61055a77d\",\"name\":\"suzuki\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"- \u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.jcc-holland.nl\/en\/21598\/","og_locale":"en_US","og_type":"article","og_title":"- \u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240","og_description":"Regenerative Medicine delegation from Japan\u00a0 You can download the list as pdf . Jun Miyagawa, Assistant to the Chairman &#8211; Nakanoshima Qross and President &amp; CEO of Miracle Science Innovation Inc \u00a0Key interest areas: Regenerative-medicine ecosystem hub; startup &amp; venture support \u00a0Website:Nakanoshima Qross\u00a0\uff08English) Nakanoshima Qross\uff08\u4e2d\u4e4b\u5cf6\u30af\u30ed\u30b9\uff09 (\u65e5\u672c\u8a9e\uff09 Hiroki Iguchi, Marketing &amp; Business Development Manager, Cell Culture Business Group\/Life Science Business Development Department &#8211; Sekisui Chemical\u00a0 Key interest areas: member of the value chain consortium for development of Mass Cell Culture System (VMaCS); cell culture scaffold material Ceglu\u2122; stable cell manufacturing Website: SEKISUI CHEMICAL CO.,LTD Keiko Okamura, Director, General Manager of Business Management Division &#8211; Gojo Medical \u00a0Key interest areas: member of [&hellip;]","og_url":"https:\/\/www.jcc-holland.nl\/en\/21598\/","og_site_name":"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240","article_published_time":"2026-10-12T10:37:43+00:00","article_modified_time":"2026-10-12T11:04:42+00:00","author":"suzuki","twitter_card":"summary_large_image","twitter_misc":{"Written by":"suzuki","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.jcc-holland.nl\/en\/21598\/#article","isPartOf":{"@id":"https:\/\/www.jcc-holland.nl\/en\/21598\/"},"author":{"name":"suzuki","@id":"https:\/\/www.jcc-holland.nl\/#\/schema\/person\/22f3f93b50b96f44a4bbeed61055a77d"},"headline":"No title","datePublished":"2026-10-12T10:37:43+00:00","dateModified":"2026-10-12T11:04:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.jcc-holland.nl\/en\/21598\/"},"wordCount":457,"publisher":{"@id":"https:\/\/www.jcc-holland.nl\/#organization"},"articleSection":["\u30ab\u30c6\u30b4\u30ea\u30fc\u306a\u3057"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.jcc-holland.nl\/en\/21598\/","url":"https:\/\/www.jcc-holland.nl\/en\/21598\/","name":"- \u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240","isPartOf":{"@id":"https:\/\/www.jcc-holland.nl\/#website"},"datePublished":"2026-10-12T10:37:43+00:00","dateModified":"2026-10-12T11:04:42+00:00","breadcrumb":{"@id":"https:\/\/www.jcc-holland.nl\/en\/21598\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.jcc-holland.nl\/en\/21598\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.jcc-holland.nl\/en\/21598\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.jcc-holland.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Uncategorized","item":"https:\/\/www.jcc-holland.nl\/en\/uncategorized\/"}]},{"@type":"WebSite","@id":"https:\/\/www.jcc-holland.nl\/#website","url":"https:\/\/www.jcc-holland.nl\/","name":"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240","description":"THE JAPANESE CHAMBER OF COMMERCE AND INDUSTRY IN THE NETHERLANDS","publisher":{"@id":"https:\/\/www.jcc-holland.nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.jcc-holland.nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.jcc-holland.nl\/#organization","name":"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240","url":"https:\/\/www.jcc-holland.nl\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.jcc-holland.nl\/#\/schema\/logo\/image\/","url":"https:\/\/www.jcc-holland.nl\/uploads\/2017\/11\/logo_JP_01.png","contentUrl":"https:\/\/www.jcc-holland.nl\/uploads\/2017\/11\/logo_JP_01.png","width":84,"height":70,"caption":"\u5728\u862d\u65e5\u672c\u5546\u5de5\u4f1a\u8b70\u6240"},"image":{"@id":"https:\/\/www.jcc-holland.nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.jcc-holland.nl\/#\/schema\/person\/22f3f93b50b96f44a4bbeed61055a77d","name":"suzuki"}]}},"_links":{"self":[{"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/posts\/21598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/comments?post=21598"}],"version-history":[{"count":5,"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/posts\/21598\/revisions"}],"predecessor-version":[{"id":21606,"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/posts\/21598\/revisions\/21606"}],"wp:attachment":[{"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/media?parent=21598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/categories?post=21598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.jcc-holland.nl\/en\/wp-json\/wp\/v2\/tags?post=21598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}